389 related articles for article (PubMed ID: 1977935)
1. Torsades de pointes occurring in association with terfenadine use.
Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
[TBL] [Abstract][Full Text] [Related]
2. Torsades de pointes complicating treatment with terfenadine.
Warin RP
BMJ; 1991 Jul; 303(6793):58. PubMed ID: 1677597
[No Abstract] [Full Text] [Related]
3. Torsades de pointes complicating treatment with terfenadine.
MacConnell TJ; Stanners AJ
BMJ; 1991 Jun; 302(6790):1469. PubMed ID: 1676921
[No Abstract] [Full Text] [Related]
4. Torsades de pointes complicating treatment with terodiline.
McLeod AA; Thorogood S; Barnett S
BMJ; 1991 Jun; 302(6790):1469. PubMed ID: 1676922
[No Abstract] [Full Text] [Related]
5. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
Tsai WC; Tsai LM; Chen JH
J Formos Med Assoc; 1997 Feb; 96(2):144-6. PubMed ID: 9071844
[TBL] [Abstract][Full Text] [Related]
6. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
Wynn RL
Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
[No Abstract] [Full Text] [Related]
7. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
8. Torsades de pointes with terfenadine ingestion.
June RA; Nasr I
Am J Emerg Med; 1997 Sep; 15(5):542-3. PubMed ID: 9270401
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular toxicity of antihistamines.
Smith SJ
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.
Pohjola-Sintonen S; Viitasalo M; Toivonen L; Neuvonen P
Eur J Clin Pharmacol; 1993; 45(2):191-3. PubMed ID: 8223844
[TBL] [Abstract][Full Text] [Related]
11. Torsade de pointes induced by terfenadine in a patient with long QT syndrome.
Koh KK; Rim MS; Yoon J; Kim SS
J Electrocardiol; 1994 Oct; 27(4):343-6. PubMed ID: 7815014
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
Pohjola-Sintonen S
Duodecim; 1993; 109(2):164-6. PubMed ID: 8013320
[No Abstract] [Full Text] [Related]
13. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
[TBL] [Abstract][Full Text] [Related]
14. Torsades de pointes from terfenadine and sotalol given in combination.
Feroze H; Suri R; Silverman DI
Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
[TBL] [Abstract][Full Text] [Related]
15. Torsades de pointes induced by nonantiarrhythmic drugs.
Tran HT
Conn Med; 1994 May; 58(5):291-5. PubMed ID: 7915666
[TBL] [Abstract][Full Text] [Related]
16. Second-generation antihistamines: the risk of ventricular arrhythmias.
DuBuske LM
Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
[TBL] [Abstract][Full Text] [Related]
17. Terfenadine should be withdrawn from clinical use.
Khilnani G
J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
[No Abstract] [Full Text] [Related]
18. Torsades de pointes occurring in association with terfenadine use.
Mathews DR; McNutt B; Okerholm R; Flicker M; McBride G
JAMA; 1991 Nov; 266(17):2375-6. PubMed ID: 1920744
[No Abstract] [Full Text] [Related]
19. Torsades de pointes after terfenadine-itraconazole interaction.
Pohjola-Sintonen S; Viitasalo M; Toivonene L; Neuvonen P
BMJ; 1993 Jan; 306(6871):186. PubMed ID: 8382980
[No Abstract] [Full Text] [Related]
20. Cardiac actions of antihistamines.
Woosley RL
Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
